Mauricio Maia
- Immunology top 5%
- Biosimilars and Bioanalytical Methods 8
-
- Monoclonal and Polyclonal Antibodies Research 13
- Epidemiology top 10%
- Influenza Virus Research Studies 7
- Respiratory viral infections research 3
- Herpesvirus Infections and Treatments 3
- Transplantation top 10%
-
- Protein purification and stability 6
- Receptor Mechanisms and Signaling 3
-
- Retinal Diseases and Treatments 6
- Co-authors
- Steven J. SwansonG. H. ScottEugen KorenGopi ShankarLinda A. ZuckermanYu Chen BarrettViswanath DevanarayanAnthony R. Mire‐Sluis
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Mauricio Maia
31 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Immunology 619
- Radiology, Nuclear Medicine and Imaging 612
- Epidemiology 308
- Transplantation 23
- Molecular Biology 543
Countries citing papers authored by Mauricio Maia
This map shows the geographic impact of Mauricio Maia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio Maia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio Maia more than expected).
Fields of papers citing papers by Mauricio Maia
This network shows the impact of papers produced by Mauricio Maia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio Maia. The network helps show where Mauricio Maia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mauricio Maia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 4 | |
| 6 | Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial | 2021 | 5 |
| 7 | Pharmacokinetic (PK) Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial | 2020 | 3 |
| 8 | 2020 | 12 | |
| 9 | 2017 | 43 | |
| 10 | 2017 | 22 | |
| 11 | 2016 | 44 | |
| 12 | 2015 | 21 | |
| 13 | 2014 | 40 | |
| 14 | 2013 | 10 | |
| 15 | To determine changes in levels of cytokines in the anterior chamber (AC) fluid of eyes in patients with diabetic macular edema (DME)whom have been treated with repeated injections of ranibizumab (RBZ) | 2013 | 1 |
| 16 | 2012 | 25 | |
| 17 | 2010 | 56 | |
| 18 | 2010 | 29 | |
| 19 | 2004 | 463 | |
| 20 | 2000 | 42 |
About Mauricio Maia
Mauricio Maia is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Biosimilars and Bioanalytical Methods (8 papers), Influenza Virus Research Studies (7 papers), Retinal Diseases and Treatments (6 papers), Protein purification and stability (6 papers), Respiratory viral infections research (3 papers), Herpesvirus Infections and Treatments (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Immunology (619 citations), Radiology, Nuclear Medicine and Imaging (612 citations) and Epidemiology (308 citations). Mauricio Maia has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Steven J. Swanson, G. H. Scott, Eugen Koren, Gopi Shankar, Linda A. Zuckerman, Yu Chen Barrett, Viswanath Devanarayan, Anthony R. Mire‐Sluis, Daniel Wierda and Elizabeth W. Shores.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.